Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, and evaluation of PD-1/PD-L1 small-molecule inhibitors bearing a rigid indane scaffold
Shi Cai, Kaizhen Wang, Zhihao Qi, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115468-115468
Closed Access | Times Cited: 11

Showing 11 citing articles:

Targeting PD-1/PD-L-1 immune checkpoint inhibition for cancer immunotherapy: success and challenges
Sadique A. Javed, Asim Najmi, Waquar Ahsan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 18
Discovery of Highly Potent Small-Molecule PD-1/PD-L1 Inhibitors with a Novel Scaffold for Cancer Immunotherapy
Yongling Xu, Huijie Du, Weibo Guo, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 5, pp. 4083-4099
Closed Access | Times Cited: 4
Discovery of Novel PD-L1 Inhibitors That Induce the Dimerization, Internalization, and Degradation of PD-L1 Based on the Fragment Coupling Strategy
Kaizhen Wang, Xiangyu Zhang, Yao Cheng, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 24, pp. 16807-16827
Closed Access | Times Cited: 9
In silico assessment of a natural small molecule as an inhibitor of programmed death ligand 1 for cancer immunotherapy: a computational approach
Nahed S. Alharthi, Maher S. Alwethaynani, Abdulfattah Yahya M. Alhazmi, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-21
Closed Access | Times Cited: 1
Discovery of bioactive natural products of microbial origin as inhibitors of the PD-1/PD-L1 protein-protein interaction
Elisabeth Domingo-Contreras, José R. Tormo, Víctor González-Menéndez, et al.
International Journal of Biological Macromolecules (2024) Vol. 264, pp. 130458-130458
Closed Access | Times Cited: 1
Design, synthesis, and optimization of novel PD-L1 inhibitors and the identification of a highly potent and orally bioavailable PD-L1 inhibitor
Tanachote Ruengsatra, Jakapun Soponpong, Nonthaneth Nalinratana, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116730-116730
Closed Access | Times Cited: 1
Extraction of indene from local pyrolysis oil and its usage for synthesis of a cationite
Saidmansur Sh. SAIDOBBOZOV, Suvonqul Nurmanov, Orifjon Qodirov, et al.
Chemical Papers (2024) Vol. 78, Iss. 15, pp. 8333-8350
Closed Access | Times Cited: 1
Discovery of Benzo[d]oxazoles as Novel Dual Small-Molecule Inhibitors Targeting PD-1/PD-L1 and VISTA Pathway
Kaizhen Wang, Shi Cai, Yao Cheng, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 20, pp. 18526-18548
Closed Access | Times Cited: 1
Computational Approach for the Development of pH-Selective PD-1/PD-L1 Signaling Pathway Inhibition in Fight with Cancer
Roderick C. McDowell, Jordhan D. Booth, Allyson McGowan, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2295-2295
Open Access
Discovery of Daclatasvir as a potential PD-L1 inhibitor from drug repurposing
Mengmeng Sun, Shixuan Lv, Yanyan Pan, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107874-107874
Closed Access
Beyond peptides: Unveiling the design strategies, structure activity correlations and protein-ligand interactions of small molecule inhibitors against pd-1/pd-l1
Pujan Sasmal, P. Prabitha, B. R. Prashantha Kumar, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108036-108036
Closed Access
Page 1

Scroll to top